BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CTD Holdings, Inc. Smashes Quarterly Sales Record


7/20/2011 6:52:45 AM

ALACHUA, FL--(Marketwire - July 20, 2011) -

CTD Holdings, Inc. (OTCQB: CTDH) (OTCBB: CTDH) is pleased to announce that the Company ended the second quarter of 2011 with $369,348 in recorded sales. This represents more than double the sales of the same period in the previous year. It is the largest quarterly sales number in the Company's history. Combined with the first quarter sales, year to date sales for the Company now total $623,714, putting CTD Holdings firmly on track to exceed a million dollars in sales for the full year.

"With a $369,000 quarter on the books, a major Trappsol® customer extending contract purchases for another two years, and the NanoSonic Products Aquaplex® pulse drying plant being opened next week," exclaimed Company Chairman C.E. "Rick" Strattan, "the management team's strategy for aggressive growth is showing continued traction and results."

A complete account of the company's operations during the second quarter will be reported on SEC Form 10Q, scheduled for timely filing in early August.

"We have chosen the right moment in time to expand the company's operations," remarked Company Director and Exec. V.P., Dr. Jeffrey Tate. "Opening the NanoSonic Products, Inc. manufacturing facility just as we enter this period of growth in demand for our Trappsol® and Aquaplex® products validates our belief in the strong growth potential for commercial uses of cyclodextrin chemistries."

About CTD Holdings, Inc.:
CTD Holdings, Inc. and its companies provide Trappsol® brand cyclodextrins and cyclodextrin derivatives, and Aquaplex® brand cyclodextrin complexes to researchers, R&D labs and industrial users in the medical, pharmaceutical, food, and nutritional industries. For more information regarding CTD Holdings, Inc., please visit: www.ctd-holdings.com.

Safe Harbor Statement:
This news release contains "forward-looking statements" about the Company's anticipated growth. You are cautioned that such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. These risks and uncertainties include the Company's ability to obtain additional capital to expand operations as planned, demand for Company products and services, and availability of products and raw materials. The above forward-looking statements are made as of the date above; CTD Holdings, Inc. accepts no specific responsibility for updating such statements.


Contact:
David Corner
386-454-0887
investor@ctd-holdings.com

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES